Show simple item record

dc.contributor.authorAbdelsalam Elshenawy, Rasha
dc.contributor.authorUmaru, Nikkie
dc.contributor.authorAslanpour, Zoe
dc.date.accessioned2024-07-05T12:30:02Z
dc.date.available2024-07-05T12:30:02Z
dc.date.issued2024-06-18
dc.identifier.citationAbdelsalam Elshenawy , R , Umaru , N & Aslanpour , Z 2024 , Report: Optimising Antimicrobial Use During the COVID-19 Pandemic in UK Acute Care Settings (2020-2024) – Insights from Three Sequential Studies .
dc.identifier.otherORCID: /0000-0002-2567-0540/work/163069070
dc.identifier.otherORCID: /0000-0002-8954-0817/work/163069073
dc.identifier.urihttp://hdl.handle.net/2299/28014
dc.description.abstractThis report presents findings from a comprehensive research project conducted in UK acute care settings, encompassing three sequential investigations. These studies included a systematic review of key antimicrobial stewardship (AMS) strategies, an analysis of patient records to observe shifts in antibiotic prescribing patterns, and a survey of healthcare professionals. The results highlighted the critical role of multidisciplinary teams in AMS (93%), an increase in inappropriate antibiotic prescribing, and significant disruptions in AMS activities during the pandemic. These findings underscore the urgent need for resilient and strategic AMS adaptations to optimise antimicrobial use, combat antimicrobial resistance, and enhance patient care and quality of life. Additionally, this research proposed practical tools for effective AMS implementation, such as the AMS framework or roadmap for implementation at both patient and organisational levels, an AMS dynamic dashboard, AMS cards, and an AMS educational programme. These tools aim to improve antibiotic prescribing and stewardship, integrate seamlessly with various systems, and offer practical solutions to antimicrobial resistance, ultimately safeguarding public health and saving patient lives. By advancing AMS practices, this project contributes to the global effort to optimise antibiotic use and improve healthcare outcomes.en
dc.format.extent438304
dc.language.isoeng
dc.subjectAntibiotic research
dc.subjectAntibiotic Prescribing
dc.subjectantibiotic duration
dc.subjectAntibiotic guardian
dc.subjectAntibiotic awareness week
dc.subjectAntibiotic resistance
dc.subjectAntibiotic review
dc.subjectAntibiotic safety
dc.subjectantimicrobial
dc.subjectantimicrobial agents
dc.subjectAntimicrobial Classification
dc.subjectantimicrobial cultures
dc.subjectoptimisation
dc.subjectMedicine optimisation
dc.subjectPharmacist
dc.subjectPharmacist role
dc.subjectPharmacists role
dc.subjectRetrospective Studies
dc.subjectProspective Studies
dc.subjectsystematic literature review
dc.subjectsystematic literature reviews
dc.subjectSystematic Review
dc.subjectCross sectional
dc.subjectMedical Records Review
dc.subjectMedical Records
dc.subjectstudy design
dc.subjectresearch project
dc.subjectResearch Method
dc.subjectResearch Registeration
dc.subjectResearch Report
dc.subjectRESEARCH REPORT
dc.subjectCovid 19 pandemic
dc.subjectNHS England
dc.subjectPublic health
dc.subjectGlobal Health
dc.subjectAcute care setting
dc.subjectSecondary care
dc.subjectMedicine Optimisation
dc.subjectmedicines
dc.subjectMedicine safety
dc.titleReport: Optimising Antimicrobial Use During the COVID-19 Pandemic in UK Acute Care Settings (2020-2024) – Insights from Three Sequential Studiesen
dc.contributor.institutionSchool of Life and Medical Sciences
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record